A legal cannabis movement is sweeping the United States and currently, 29 states and the District of Columbia have legalized medical marijuana and eight states have legalized recreational marijuana.

Although recent studies have shown that cannabis has medical benefits, the DEA and FDA still have it classified as a Schedule I substance. The Schedule I category is reserved for substances that have the highest potential for abuse, that have no accepted medical use and even under medical supervision cannot be used safely.

Tech investors are turning to cannabis – giving seed capital a whole new meaning.

When you hear that the th Annual Cannabis World Congress and Business Expo is in New York City and taking over a corner of the Jacob Javits Center – the 12th largest convention center in the US – attention must be paid.

Producing a few pounds of weed can have the same environmental toll as driving across America seven times – harming cities’ and states’ plans to curb emissions.

As he opens the steel door to the jumble of his office, located in a cloistered warehouse on the west side of Denver, Paul Isenbergh is barking down the phone about a duplicitous business rival. He’s wearing a shirt and rust-colored tie. Yards from his desk, rows of drying cannabis plants are strung up on two clothes lines.

Isenbergh spent 30 years as a real estate broker in Florida. When he moved to Denver in 2011, he didn’t even know medicinal marijuana was legal in Colorado. 

INTIVA BioPharma Inc. has filed a provisional patent application with the United States Patent Office for methods and compositions for treating lipidosis. The methods comprise the administration of a drug comprising of one or more cannabinoids and/or terpenes.

Lipidosis is a term used to describe various lysosmal storage diseases in which there is an abnormal accumulation of lipids in the reticuloendothelial cells. Examples of lipidosis conditions include Gaucher’s Disease, Neimann-Pick Disease, Fabry’s Disease, Wolman’s Disease, van Bogaert’s Disease, Generalized (GM1) ganliosidosis, Tay-Sachs Disease, Sultatide Lipidosis and Krabbe’s Disease.

This summer, the Uk’s first medical cannabis research facility is going to open – studying the medical uses of weed for the first time in this country.

Do they need any volunteers, we wonder?

The facility will be opened by Medipen – who tested a cannabis vaporiser with the NHS last year.

The Medipen contains ‘cannabidiol’ (CBD), a chemical from cannabis which campaigners claim helps with diseases including cancer and Crohn’s disease.

Crucially, the oil doesn’t contain any THC, the chemical in cannabis which causes the high – and it is legal in the UK.

But in the new facility – at an as-yet-undisclosed location – will explore the use of THC (the chemical in cannabis which gets you stoned) as a treatment for cancer patients.

Tradiv's online marketplace for wholesale marijuana connects growers and retailers on a transparent platform, replacing the industry's gray-market pot brokers and backroom deals.

Somewhere between Somalia and Yemen in 2012, Aeron Sullivan, a Marine captain of the 3rd Assault Amphibian Battalion, was aboard the U.S.S. New Orleans thinking about the war on drugs.

His battalion floated around North Africa to stop Somali pirates from running drugs to terrorist groups like al Qaeda and ISIS. The "Big Easy" would spot the pirates, detain them, and seize the assets, mostly opium and munitions. With cooperation from regional governments, the pirates would be sent to prison and the drugs would be destroyed.

It had been about a year since retailers in Washington state began selling recreational marijuana when Ryan Porter, a vet of the automotive technology industry, saw his opportunity.

He had been consulting for another cannabis startup and saw the need for an automated system that could help marijuana dispensaries manage and track their inventory. Taking the lessons he learned building digital products for AutoNation, Porter launched Grassworks Digital.

“Our core product is Simple Marijuana Menu, which integrates with clients’ point of sale systems, automates inventory updates, and allows consumers to order online,” he said. “Our mission is to be at the forefront of cannabis retail technology.”

Cannabis is an incredible plant. It is richly flavorful, fragrant and delivers a boundless array of therapeutic and recreational benefits. But not everyone wants to, or should, inhale burning plant material on a regular basis.

As science and technology increasingly enter the world of cannabis, more of us are seeking out premium products that deliver the best flavors, aromas and effects, without the harsh smoke and resin that accompany an old fashioned joint or bong hit.

Denver-based Evolab has led the way in implementing advanced technologies to transform premium raw cannabis into the best extracts and products. Evolab’s Alchemy™ oils are a perfect example of the evolution of cannabis products in legal markets.

BlackSwan enters the Delivery Pen and Supplements Markets with I+huntr Brand, Tailored for Performance Athletes, Powered by MyDx360

Is marijuana good medicine for those suffering from cancer? Definitely. Even the federal government agrees that “cannabinoids may have benefits in the treatment of cancer-related side effects.” Can marijuana cure cancer? That answer remains elusive, but there are no clinical studies demonstrating that marijuana will remove cancerous tumors from the body.

CURE Pharmaceutical, a California-based technology company, revealed last month that it will be conducting a groundbreaking clinical study to test whether cannabis can kill or reduce cancerous cells.